Figure 3 - Clinical Significance, Species Distribution, and Temporal Trends of Nontuberculous Mycobacteria, Denmark, 1991–2022 - Volume 30, Number 9—September 2024 - Emerging Infectious Diseases journal (2024)

Figure 3. Annual absolute number of patients with a first culture positive for MAC, corresponding incidence rates, and annual incidence rates for the most frequent nontuberculous mycobacteria species for patients with definite and possible pulmonary disease combined, Denmark, 1991–2022. A) Numbers of first MAC cases by year and annual incidence (infections/1 million persons). B) Annual incidence rates (infections/1 million persons) of the most frequent nontuberculous mycobacteria species. Species were grouped by using phylogenetic classifications described by Tortoli et al. (7). Other was defined as Mycobacteria spp. and species with <15 cases reported throughout the study period. MAC, Mycobacterium avium complex.

1. Dahl VN, Mølhave M, Fløe A, van Ingen J, Schön T, Lillebaek T, et al. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int J Infect Dis. 2022;125:120–31. DOIPubMedGoogle Scholar

2. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. DOIPubMedGoogle Scholar

3. Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020;56:

   2000535

   . DOIPubMedGoogle Scholar

4. Andréjak C, Thomsen VO, Johansen IS, Riis A, Benfield TL, Duhaut P, et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med. 2010;181:514–21. DOIPubMedGoogle Scholar

   See Also

   Figure 1 - Clinical Significance, Species Distribution, and Temporal Trends of Nontuberculous Mycobacteria, Denmark, 1991–2022 - Volume 30, Number 9—September 2024 - Emerging Infectious Diseases journal

5. Hermansen TS, Ravn P, Svensson E, Lillebaek T. Nontuberculous mycobacteria in Denmark, incidence and clinical importance during the last quarter-century. Sci Rep. 2017;7:6696. DOIPubMedGoogle Scholar

6. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010;182:977–82. DOIPubMedGoogle Scholar

7. Tortoli E, Fedrizzi T, Meehan CJ, Trovato A, Grottola A, Giacobazzi E, et al. The new phylogeny of the genus Mycobacterium: The old and the news. Infect Genet Evol. 2017;56:19–25. DOIPubMedGoogle Scholar

8. Thomsen VO, Andersen AB, Miörner H. Incidence and clinical significance of non-tuberculous mycobacteria isolated from clinical specimens during a 2-y nationwide survey. Scand J Infect Dis. 2002;34:648–53. DOIPubMedGoogle Scholar

9. Kwak N, Dalcolmo MP, Daley CL, Eather G, Gayoso R, Hasegawa N, et al. M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis. Eur Respir J. 2019;54:

   1801991

   . DOIPubMedGoogle Scholar

10. Diel R, Ringshausen F, Richter E, Welker L, Schmitz J, Nienhaus A. Microbiological and clinical outcomes of treating non–Mycobacterium avium complex nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis. Chest. 2017;152:120–42. DOIPubMedGoogle Scholar

11. Diel R, Nienhaus A, Ringshausen FC, Richter E, Welte T, Rabe KF, et al. Microbiologic outcome of interventions against Mycobacterium avium complex pulmonary disease: a systematic review. Chest. 2018;153:888–921. DOIPubMedGoogle Scholar

12. van Ingen J, Bendien SA, de Lange WC, Hoefsloot W, Dekhuijzen PN, Boeree MJ, et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax. 2009;64:502–6. DOIPubMedGoogle Scholar

13. Vande Weygaerde Y, Cardinaels N, Bomans P, Chin T, Boelens J, André E, et al. Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis. BMC Infect Dis. 2019;19:1061. DOIPubMedGoogle Scholar

14. Al-Mahruqi SH, van-Ingen J, Al-Busaidy S, Boeree MJ, Al-Zadjali S, Patel A, et al. Clinical relevance of nontuberculous Mycobacteria, Oman. Emerg Infect Dis. 2009;15:292–4. DOIPubMedGoogle Scholar

15. Schiff HF, Jones S, Achaiah A, Pereira A, Stait G, Green B. Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital. Sci Rep. 2019;9:1730. DOIPubMedGoogle Scholar

16. Simons S, van Ingen J, Hsueh PR, Van Hung N, Dekhuijzen PN, Boeree MJ, et al. Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis. 2011;17:343–9. DOIPubMedGoogle Scholar

17. Jankovic M, Samarzija M, Sabol I, Jakopovic M, Katalinic Jankovic V, Zmak L, et al. Geographical distribution and clinical relevance of non-tuberculous mycobacteria in Croatia. Int J Tuberc Lung Dis. 2013;17:836–41. DOIPubMedGoogle Scholar

18. Gerogianni I, Papala M, Kostikas K, Petinaki E, Gourgoulianis KI. Epidemiology and clinical significance of mycobacterial respiratory infections in Central Greece. Int J Tuberc Lung Dis. 2008;12:807–12.PubMedGoogle Scholar

19. Dabó H, Santos V, Marinho A, Ramos A, Carvalho T, Ribeiro M, et al. Nontuberculous mycobacteria in respiratory specimens: clinical significance at a tertiary care hospital in the north of Portugal. J Bras Pneumol. 2015;41:292–4. DOIPubMedGoogle Scholar

20. Al-Harbi A, Al-Jahdali H, Al-Johani S, Baharoon S, Bin Salih S, Khan M. Frequency and clinical significance of respiratory isolates of non-tuberculous mycobacteria in Riyadh, Saudi Arabia. Clin Respir J. 2016;10:198–203. DOIPubMedGoogle Scholar

21. Brode SK, Marchand-Austin A, Jamieson FB, Marras TK. Pulmonary versus nonpulmonary nontuberculous mycobacteria, Ontario, Canada. Emerg Infect Dis. 2017;23:1898–901. DOIPubMedGoogle Scholar

22. Russell CD, Claxton P, Doig C, Seagar AL, Rayner A, Laurenson IF. Non-tuberculous mycobacteria: a retrospective review of Scottish isolates from 2000 to 2010. Thorax. 2014;69:593–5. DOIPubMedGoogle Scholar

23. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182:970–6. DOIPubMedGoogle Scholar

24. Wetzstein N, Dahl VN, Lillebaek T, Lange C. Clinical spectrum and relevance of Mycobacterium malmoense: Systematic review and meta-analysis of 859 patients. J Infect. 2024;89:

    106203

    . DOIPubMedGoogle Scholar

25. Jankovic M, Sabol I, Zmak L, Jankovic VK, Jakopovic M, Obrovac M, et al. Microbiological criteria in non-tuberculous mycobacteria pulmonary disease: a tool for diagnosis and epidemiology. Int J Tuberc Lung Dis. 2016;20:934–40. DOIPubMedGoogle Scholar

26. Marras TK, Nelson P, Peci A, Richard-Greenblatt M, Brode S, Sullivan A, et al. Pulmonary nontuberculous mycobacteria, Ontario, Canada, 2020. Emerg Infect Dis. 2023;29:1415–9. DOIPubMedGoogle Scholar

27. van Ingen J. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease. Clin Chest Med. 2015;36:43–54. DOIPubMedGoogle Scholar

28. Yan M, Brode SK, Marras TK. Treatment of the less common nontuberculous mycobacterial pulmonary disease. Clin Chest Med. 2023;44:799–813. DOIPubMedGoogle Scholar

29. Dahl VN, Laursen LL, He Y, Zhang YA, Wang MS. Species distribution among patients with nontuberculous mycobacteria pulmonary disease in Europe. J Infect. 2023;87:469–72. DOIPubMedGoogle Scholar

30. Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, et al.; Nontuberculous Mycobacteria Network European Trials Group. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42:1604–13. DOIPubMedGoogle Scholar

31. Hoefsloot W, Boeree MJ, van Ingen J, Bendien S, Magis C, de Lange W, et al. The rising incidence and clinical relevance of Mycobacterium malmoense: a review of the literature. Int J Tuberc Lung Dis. 2008;12:987–93.PubMedGoogle Scholar

32. Zweijpfenning SMH, Ingen JV, Hoefsloot W. Geographic distribution of nontuberculous mycobacteria isolated from clinical specimens: a systematic review. Semin Respir Crit Care Med. 2018;39:336–42. DOIPubMedGoogle Scholar

33. Prevots DR, Marshall JE, Wagner D, Morimoto K. Global epidemiology of nontuberculous mycobacterial pulmonary disease: a review. Clin Chest Med. 2023;44:675–721. DOIPubMedGoogle Scholar

34. Dahl VN, Fløe A, Wejse C. Nontuberculous mycobacterial infections in a Danish region between 2011 and 2021: evaluation of trends in diagnostic codes. Infect Dis (Lond). 2023;55:439–43. DOIPubMedGoogle Scholar

35. Pedersen AA, Løkke A, Fløe A, Ibsen R, Johansen IS, Hilberg O. Nationwide increasing incidence of nontuberculous mycobacterial diseases among adults in Denmark: eighteen years of follow-up. Chest. 2024;S0012-3692(24)00393-3.

36. Mejia-Chew C, Yaeger L, Montes K, Bailey TC, Olsen MA. Diagnostic accuracy of health care administrative diagnosis codes to identify nontuberculous mycobacteria disease: a systematic review. Open Forum Infect Dis. 2021;8:

    ofab035

    . DOIPubMedGoogle Scholar

37. Loebinger MR, Quint JK, van der Laan R, Obradovic M, Chawla R, Kishore A, et al. Risk factors for nontuberculous mycobacterial pulmonary disease: a systematic literature review and meta-analysis. Chest. 2023;164:1115–24. DOIPubMedGoogle Scholar